We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IVBT market cap is 17.98k. The company's latest EPS is USD -0.6266 and P/E is 0.00.
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 79k | 1,000 | 3k | 0 | 0 |
| Operating Income | -667k | -217k | -239k | -5.25M | -1.37M |
| Net Income | -170k | -2.58M | 1.04M | -41.58M | -14.08M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 256k | 209k | 182k | 43.96M | 76k |
| Total Liabilities | 224k | 2.89M | 407k | 41.11M | 3.51M |
| Total Equity | 32k | -2.68M | -225k | 2.85M | -3.43M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -776k | -410k | -30k | -3.13M | -620k |
| Investing | -6k | -300k | N/A | -853k | N/A |
| Financing | 27k | 709k | 150k | 4M | 514k |
| Market Cap | 17.98k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 22.47M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.0008 |
| 52 Week Low | 0.0008 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Innovation1 Biotech Inc (CE) |
| Address |
1810 east sahara avenue las vegas, nevada 89104 |
| Website | https://www.innovation1bio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
